Allovir Inc (ALVR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
Operating Expenses | 23,900 | 12,153 | 9,840 | 0 | 8,478 |
Operating Income | -23,900 | -12,153 | -9,840 | N/A | -8,478 |
Other Income | 286 | 521 | 501 | 0 | 1,208 |
Pre-tax Income | -23,614 | -11,632 | -9,339 | 0 | -7,270 |
Net Income Continuous | -23,614 | -11,632 | -9,339 | N/A | -7,270 |
Net Income | $-23,614 | $-11,632 | $-9,339 | $N/A | $-7,270 |
EPS Basic Total Ops | -0.58 | -4.43 | -4.21 | N/A | -4.97 |
EPS Basic Continuous Ops | -0.58 | -4.43 | -4.21 | N/A | -4.97 |
EPS Diluted Total Ops | -0.58 | -4.43 | -4.21 | N/A | -4.97 |
EPS Diluted Continuous Ops | -0.58 | -4.43 | -4.21 | N/A | -4.97 |
EBITDA(a) | $-23,882 | $-12,134 | $-9,822 | $N/A | $-8,478 |